7 Recruiting Recurrent Ovarian Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Recruiting Recurrent Ovarian Cancer Studies
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer.
📍 Duke Cancer Center — Durham, North Carolina
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Phase 1 Study of RP-6306 With Carboplatin and Paclitaxel in TP53 Ovarian and Uterine Cancer
📍 Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha Expression
📍 University of California Los Angeles /ID# 269339 — Los Angeles, California
View Study & Checklist ➔ 🟡 Not Yet Recruiting Interventional Protocol 📊 Observational Clinical Research
Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
📍 University of Alabama_6th Ave — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
CPI-0209 Plus Carboplatin in Patients With Platinum Sensitive Recurrent Ovarian Cancer
📍 Magee-Womens Research Institute / UPMC Magee Womens Hospital — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Combination Therapy for Recurrent Ovarian Cancer
📍 UofL Health Brown Cancer Center — Louisville, Kentucky
View Study & Checklist ➔